All
Results: 14101-14112 of 78173

ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer

A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

M-Cube and SOLUM Enter Strategic Partnership to Deliver Integrated Digital Signage and ESL Solutions for Retail Across Europe








